Investing Profile

Brian Daniels

InvestorVC
Partner at 5AM Ventures
5amventures.comSan Francisco Bay Area
Photo of Brian Daniels, Partner at 5am Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Massachusetts Institute of Technology Network
392 CONNECTIONS
Massachusetts Institute of Technology Network
392 CONNECTIONS
Boston Consulting Group (BCG) Network
288 CONNECTIONS
Merck Network
36 CONNECTIONS
University of Central Florida Network
16 CONNECTIONS
cb
5am Ventures Partner
$100K - $5.0M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
RareCyte
Series GSep 2021$24M
Series FDec 2019$22M
Series UnknownAug 2017$30M
$76M
Co-investors: Robert Weisskoff (F-Prime Capital Partners), Robert Shepler (Telegraph Hill Partners), David Kabakoff (HealthQuest Capital), Jan Garfinkle (Arboretum Ventures)
Artiva Biotherapeutics
Series BFeb 2021$120M
Series AJun 2020$78M
$200M
Co-investors: Yvonne Yamanaka (venBio), Laura Stoppel (RA Capital Management), Bong Koh (Venrock)
Inipharm
Series ANov 2020$35M
$35M
Co-investors: Daniel Estes (Frazier Healthcare Partners)
Spyryx Biosciences
Series AMay 2015$18M
$18M
Co-investors: Tim Shannon (Canaan Partners), Christy Shaffer (Hatteras Venture Partners)
Director, Immunology MerckPresent
Vice President, Immunology Bristol Myers SquibbPresent
Senior Vice President (retired), Global Development and Medical Affairs Bristol Myers SquibbPresent
Senior Advisor Boston Consulting Group (BCG)Present
Board Member Novo NordiskPresent
Board Member Artiva BiotherapeuticsPresent
Board Member cslPresent
Venture Partner 5AM VenturesPresent
Partner 5AM VenturesPresent
University of Central Florida BS Biology/Biological Sciences, General
Massachusetts Institute of Technology BS Biology/Biological Sciences, General
University of Central Florida M.S. Biology, General
Massachusetts Institute of Technology M.S. Biology, General